Table I.
Treatment group, % | ||
---|---|---|
Clinicopathological features | RT-WF | WF |
Total, n | 22.0 | 20.0 |
Age at diagnosis, years ± SD | 60.1±9.6 | 55.0±10.2 |
Histological type | ||
Ductal | 59.1 | 65.0 |
Lobular | 22.7 | 35.0 |
Other | 18.2 | 0.0 |
ER status | ||
Positive | 100.0 | 95.0 |
Negative | 0.0 | 5.0 |
HER2 status | ||
Positive | 0.0 | 10.0 |
Negative | 100.0 | 90.0 |
Molecular classification | ||
Triple negative | 0.0 | 5.0 |
Non-triple negative | 100.0 | 95.0 |
Histological grade | ||
G1 | 40.9 | 25.0 |
G2 | 31.8 | 55.0 |
G3 | 27.3 | 20.0 |
SD, standard deviation; WF, post-operative wound fluid; RT-WF, post-operative and post-intraoperative radiotherapy wound fluid; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2.